1 Study Coverage
1.1 Non-invasive Cancer Diagnosis Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million) Introduction
1.2 Global Non-invasive Cancer Diagnosis Outlook 2017 VS 2022 VS 2028
1.2.1 Global Non-invasive Cancer Diagnosis Market Size for the Year 2017-2028
1.2.2 Global Non-invasive Cancer Diagnosis Market Size for the Year 2017-2028
1.3 Non-invasive Cancer Diagnosis Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Non-invasive Cancer Diagnosis in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Non-invasive Cancer Diagnosis Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Non-invasive Cancer Diagnosis Market Dynamics
1.4.1 Non-invasive Cancer Diagnosis Industry Trends
1.4.2 Non-invasive Cancer Diagnosis Market Drivers
1.4.3 Non-invasive Cancer Diagnosis Market Challenges
1.4.4 Non-invasive Cancer Diagnosis Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Non-invasive Cancer Diagnosis by Type
2.1 Non-invasive Cancer Diagnosis Market Segment by Type
2.1.1 Clinical Chemistry
2.1.2 Immunochemistry/Immunoassay
2.1.3 Molecular Diagnostics
2.1.4 Others
2.2 Global Non-invasive Cancer Diagnosis Market Size by Type (2017, 2022 & 2028)
2.3 Global Non-invasive Cancer Diagnosis Market Size by Type (2017-2028)
2.4 United States Non-invasive Cancer Diagnosis Market Size by Type (2017, 2022 & 2028)
2.5 United States Non-invasive Cancer Diagnosis Market Size by Type (2017-2028)
3 Non-invasive Cancer Diagnosis by Application
3.1 Non-invasive Cancer Diagnosis Market Segment by Application
3.1.1 Blood Cancer
3.1.2 Solid Tumors
3.1.3 Breast Cancer
3.1.4 Lung Cancer
3.1.5 Others
3.2 Global Non-invasive Cancer Diagnosis Market Size by Application (2017, 2022 & 2028)
3.3 Global Non-invasive Cancer Diagnosis Market Size by Application (2017-2028)
3.4 United States Non-invasive Cancer Diagnosis Market Size by Application (2017, 2022 & 2028)
3.5 United States Non-invasive Cancer Diagnosis Market Size by Application (2017-2028)
4 Global Non-invasive Cancer Diagnosis Competitor Landscape by Company
4.1 Global Non-invasive Cancer Diagnosis Market Size by Company
4.1.1 Top Global Non-invasive Cancer Diagnosis Companies Ranked by Revenue (2021)
4.1.2 Global Non-invasive Cancer Diagnosis Revenue by Player (2017-2022)
4.2 Global Non-invasive Cancer Diagnosis Concentration Ratio (CR)
4.2.1 Non-invasive Cancer Diagnosis Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Non-invasive Cancer Diagnosis in 2021
4.2.3 Global Non-invasive Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Non-invasive Cancer Diagnosis Headquarters, Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million) Type
4.3.1 Global Non-invasive Cancer Diagnosis Headquarters and Area Served
4.3.2 Global Non-invasive Cancer Diagnosis Companies Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Non-invasive Cancer Diagnosis Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Non-invasive Cancer Diagnosis Market Size by Company
4.5.1 Top Non-invasive Cancer Diagnosis Players in United States, Ranked by Revenue (2021)
4.5.2 United States Non-invasive Cancer Diagnosis Revenue by Players (2020, 2021 & 2022)
5 Global Non-invasive Cancer Diagnosis Market Size by Region
5.1 Global Non-invasive Cancer Diagnosis Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Non-invasive Cancer Diagnosis Market Size by Region (2017-2028)
5.2.1 Global Non-invasive Cancer Diagnosis Market Size by Region: 2017-2022
5.2.2 Global Non-invasive Cancer Diagnosis Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Non-invasive Cancer Diagnosis Market Size YoY Growth 2017-2028
6.1.2 North America Non-invasive Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Non-invasive Cancer Diagnosis Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Non-invasive Cancer Diagnosis Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Non-invasive Cancer Diagnosis Market Size YoY Growth 2017-2028
6.3.2 Europe Non-invasive Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Non-invasive Cancer Diagnosis Market Size YoY Growth 2017-2028
6.4.2 Latin America Non-invasive Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Non-invasive Cancer Diagnosis Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Non-invasive Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Gen-Probe Inc.
7.1.1 Gen-Probe Inc. Company Details
7.1.2 Gen-Probe Inc. Business Overview
7.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Introduction
7.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.1.5 Gen-Probe Inc. Recent Development
7.2 A&G Pharmaceutical
7.2.1 A&G Pharmaceutical Company Details
7.2.2 A&G Pharmaceutical Business Overview
7.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Introduction
7.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.2.5 A&G Pharmaceutical Recent Development
7.3 Affymetrix Inc.
7.3.1 Affymetrix Inc. Company Details
7.3.2 Affymetrix Inc. Business Overview
7.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Introduction
7.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.3.5 Affymetrix Inc. Recent Development
7.4 Digene Corporation
7.4.1 Digene Corporation Company Details
7.4.2 Digene Corporation Business Overview
7.4.3 Digene Corporation Non-invasive Cancer Diagnosis Introduction
7.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.4.5 Digene Corporation Recent Development
7.5 Quest Diagnostics Inc.
7.5.1 Quest Diagnostics Inc. Company Details
7.5.2 Quest Diagnostics Inc. Business Overview
7.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Introduction
7.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.5.5 Quest Diagnostics Inc. Recent Development
7.6 BioView Inc.
7.6.1 BioView Inc. Company Details
7.6.2 BioView Inc. Business Overview
7.6.3 BioView Inc. Non-invasive Cancer Diagnosis Introduction
7.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.6.5 BioView Inc. Recent Development
7.7 LabCorp
7.7.1 LabCorp Company Details
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Non-invasive Cancer Diagnosis Introduction
7.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.7.5 LabCorp Recent Development
7.8 AVIVA Biosciences Corporation
7.8.1 AVIVA Biosciences Corporation Company Details
7.8.2 AVIVA Biosciences Corporation Business Overview
7.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Introduction
7.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.8.5 AVIVA Biosciences Corporation Recent Development
7.9 Precision Therapeutics
7.9.1 Precision Therapeutics Company Details
7.9.2 Precision Therapeutics Business Overview
7.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Introduction
7.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
7.9.5 Precision Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
